Literature DB >> 8024196

Development of antisense therapeutics. Implications for cancer gene therapy.

J F Milligan1, R J Jones, B C Froehler, M D Matteucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8024196     DOI： 10.1111/j.1749-6632.1994.tb21715.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  New modalities in oncology: antisense oligonucleotides.

Authors:  C Casey Cunningham
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-04

Review 2.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

Review 3.  Antisense oncogene and tumor suppressor gene therapy of cancer.

Authors:  W W Zhang
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

4.  An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers.

Authors:  M A Bonham; S Brown; A L Boyd; P H Brown; D A Bruckenstein; J C Hanvey; S A Thomson; A Pipe; F Hassman; J E Bisi
Journal:  Nucleic Acids Res       Date:  1995-04-11       Impact factor: 16.971

5.  Synthesis of 3H-labeled nucleoside-methyl[CT3]phosphonamidite and incorporation into methylphosphonate oligonucleotides for biodistribution and biostability studies.

Authors:  M M Vaghefi; R C Fazio; K M Young; W B Marvin
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

6.  Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance.

Authors:  D Byrne; C Daly; R Nicamhlaoibh; A Howlett; K Scanlon; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

Review 7.  Ribozyme therapy: RNA enzymes to the rescue.

Authors:  Antony M Jose
Journal:  Yale J Biol Med       Date:  2002 Jul-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.